ROLE OF PRO- AND ANTI-INFLAMMATORY INTERLEUKINS IN PERIODONTITIS: MOLECULAR, IMMUNOLOGICAL, AND THERAPEUTIC SIGNIFICANCE
Open Access
- 26 August 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Abstract
Periodontitis is a chronic, biofilm-associated inflammatory disease in which tissue destruction reflects an altered host immune response more than the direct action of bacteria alone. This structured narrative review examines the molecular, immunological, diagnostic, and therapeutic significance of pro- and anti-inflammatory interleukins in periodontitis. A targeted literature search was performed in PubMed/MEDLINE, PubMed Central, Scopus, Web of Science, and Google Scholar for English-language publications from 2016 to 2026. Search terms combined 'periodontitis,' 'periodontal disease,' 'interleukin,' 'cytokine,' 'IL-1β,' 'IL-6,' 'IL-10,' 'IL-17,' 'IL-23,' 'IL-33,' 'IL-35,' 'IL-38,' 'inflammasome,' 'saliva,' and 'gingival crevicular fluid.' In the expanded search, 106 records were screened by title and abstract, 53 full-text papers were assessed, and 35 peer-reviewed publications were selected because they directly addressed interleukin expression, signaling, biomarker value, genetic variation, or therapeutic modulation in periodontal disease. Overall, IL-1β and IL-6 remain the most consistent salivary and gingival crevicular fluid biomarkers of disease severity. The IL-23/IL-17 pathway links adaptive immunity with neutrophil recruitment, RANKL expression, and osteoclastogenesis, whereas IL-10, IL-35, and IL-38 illustrate the importance of regulatory cytokine networks. Interleukin-directed therapy is not yet ready for routine periodontal use, but local, phenotype-guided immunomodulation may become a rational adjunct to conventional periodontal treatment.Keywords
This publication has 35 references indexed in Scilit:
- Effectiveness of local Tocilizumab administration in mitigating alveolar bone loss and inflammation in experimental periodontitisScientific Reports, 2025
- Levels of IL‐1β, MMP‐8, and MMP‐9 in the Saliva of Subjects With Periodontitis: A Systematic Review and Meta‐AnalysisJournal of Clinical Laboratory Analysis, 2025
- Type I interferon protects against bone loss in periodontitis by mitigating an interleukin (IL)-17-neutrophil axisLife Sciences, 2025
- Genetic Variants of the IL‐23/IL‐17 Axis and Its Association With Periodontal Disease: A Systematic ReviewImmunity, Inflammation and Disease, 2025
- The IL-33/ST2 axis is protective against acute inflammation during the course of periodontitisNature Communications, 2024
- Protein-based salivary biomarkers for the diagnosis of periodontal diseases: Systematic review and meta-analysisJournal of Taibah University Medical Sciences, 2022
- Role of interleukin-1 and inflammasomes in oral diseaseJournal of Oral Biosciences, 2020
- Inflammasomes as contributors to periodontal diseaseJournal of Periodontology, 2020
- A Systematic Review and Meta-analysis of Clinical, Immunological, and Microbiological Shift in Periodontitis After Nonsurgical Periodontal Therapy With Adjunctive Use of ProbioticsJournal of Evidence-Based Dental Practice, 2020
- Interleukin-10 polymorphisms (rs1800871, rs1800872 and rs1800896) and periodontitis risk: A meta-analysisArchives of Oral Biology, 2019